ARCHIVES

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992

GAO Report Refutes Charges Against Control Program

May 30, 1980

NCI Contract Awards.

February 18, 2000

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

Carcinogenesis, Epidemiology, Smoking RFAs Get DCCP Board Okay

June 12, 1981

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007